Wordt geladen...
Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is often diagnosed at an advanced stage and has a dismal prognosis. Nearly 10 years after the approval of cetuximab, anti-PD1/PD-L1 checkpoint inhibitors are the first drugs that have shown any survival benefit for the treatment on platinum-refractory re...
Bewaard in:
| Gepubliceerd in: | Int J Mol Sci |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6862353/ https://ncbi.nlm.nih.gov/pubmed/31671550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20215399 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|